Vitalhub

VitalHub reported Q1 2026 EPS of CAD 0.045, missing the estimate of CAD 0.0593, while revenue of CAD 31.9 million slightly beat expectations. Revenue rose 47% year‑over‑year due to acquisitions, and the adjusted EBITDA margin improved to 25%. The company shows CAD 121.3 million in cash and no debt, and cites AI products and geographic expansion as growth drivers. After the results the stock climbed 2.14% to CAD 8.11. » Więcej na de.investing.com

At the annual general meeting on 26 June 2026, Vitalhub will propose electing Allan Brett and Andrew Shen to the board and intends to appoint Allan Brett as chair. The two will replace Francis Shen and Roger Dent, who will step down at the close of the meeting; Francis Shen will remain with the company in an advisory role. Allan Brett was long CFO at The Descartes Systems Group and Aastra, and Andrew Shen is co‑founder of Shen Capital Partners and a significant shareholder. The company views the changes as a planned transition to support its next phase of growth. » Więcej na de.investing.com

Vitalhub reported Q4 2025 EPS of CAD 0.0593 (forecast CAD 0.04) and revenue of CAD 31.39m (forecast CAD 30.85m), and for the first time achieved annual revenue above CAD 100m. Gross margin fell to 79% and revenue showed a sequential decline, which worried investors and pushed the stock down 1.41% after-hours. Adjusted EBITDA rose 48% to CAD 7.4m and ARR grew 10% to CAD 96.1m. Management expects revenue contributions from AI initiatives and integration synergies from mid-2026, but sees risks from margin pressure, integration costs and macroeconomic factors. » Więcej na de.investing.com